Health Care [ 7/12 ] | Health Care Equipment & Supplies [ 49/73 ]
NASDAQ | Common Stock
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.
The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.
The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 29, 25 | 0.92 Increased by +162.86% | 0.45 Increased by +106.60% |
| Apr 28, 25 | 0.70 Increased by +100.00% | 0.24 Increased by +190.10% |
| Feb 24, 25 | 0.19 Increased by +58.33% | 0.22 Decreased by -13.64% |
| Oct 28, 24 | 0.12 Increased by +115.38% | 0.29 Decreased by -58.62% |
| Jul 31, 24 | 0.35 Increased by +1.27 K% | 0.21 Increased by +66.67% |
| Apr 30, 24 | 0.35 Increased by +537.50% | -0.04 Increased by +975.00% |
| Feb 26, 24 | 0.12 Increased by +157.14% | -0.03 Increased by +500.00% |
| Nov 6, 23 | -0.78 Decreased by -212.00% | -0.16 Decreased by -387.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 157.37 M Increased by +37.68% | 34.91 M Increased by +186.26% | Increased by +22.18% Increased by +107.93% |
| Mar 31, 25 | 143.54 M Increased by +48.21% | 25.68 M Increased by +110.56% | Increased by +17.89% Increased by +42.07% |
| Dec 31, 24 | 121.62 M Increased by +49.83% | 6.86 M Increased by +70.11% | Increased by +5.64% Increased by +13.53% |
| Sep 30, 24 | 108.76 M Increased by +63.72% | 4.22 M Increased by +116.58% | Increased by +3.88% Increased by +110.13% |
| Jun 30, 24 | 114.31 M Increased by +117.87% | 12.19 M Increased by +1.32 K% | Increased by +10.67% Increased by +659.13% |
| Mar 31, 24 | 96.85 M Increased by +133.07% | 12.20 M Increased by +562.71% | Increased by +12.59% Increased by +298.53% |
| Dec 31, 23 | 81.17 M Increased by +158.72% | 4.03 M Increased by +159.99% | Increased by +4.97% Increased by +123.19% |
| Sep 30, 23 | 66.43 M Increased by +158.65% | -25.42 M Decreased by -242.34% | Decreased by -38.27% Decreased by -32.35% |